|
Match
|
Document |
Document Title |
|
|
US20090060932 |
Groups Of Borrelia Burgdorferi And Borrelia Afzelii That Cause Lyme Disease In Humans
The present invention is drawn to an immunogenic composition comprising OspC polypeptides from Lyme Disease causing Borrelia. In one embodiment, the immunogenic composition of the present...
|
|
|
US20080112965 |
Chlamydia OMP antigen
The present invention provides purified and isolated polynucleotide molecules that encode Chlamydia polypeptides which can be used in methods to prevent, treat, and diagnose Chlamydia ...
|
|
|
US20080107676 |
PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is...
|
|
|
US20080107675 |
PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is...
|
|
|
US20080107674 |
PROTEINASE K RESISTANT SURFACE PROTEIN OF NEISSERIA MENINGITIDIS
The identification of a highly conserved, immunologically accessible antigen at the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is...
|
|
|
US20080102112 |
CHLAMYDIA VACCINES
Vaccine preparations are provided for the prevention of Chlamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and...
|
|
|
US20080102079 |
Poultry Vaccine, for Necrotic Enteritis, Comprising a Mutated Clostridium Perfringens Alpha Toxin Antigen, and Methods of Producing the Vaccine
This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic ...
|
|
|
US20080095793 |
Chlamydia flagellar protein antigen
The present invention provides purified and isolated polynucleotide molecules that encode Chlamydia polypeptides which can be used in methods to prevent, treat, and diagnose Chlamydia ...
|
|
|
US20080095792 |
Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus
The present invention features polypeptides comprising an amino acid sequence structurally related to SEQ ID NO: 1 and uses of such polypeptides. SEQ ID NO: 1 is a truncated derivative of a full...
|
|
|
US20080089899 |
Streptococcus pneumoniae proteins and nucleic
Protein antigens from Streptococcus pneumoniae are disclosed, together with nucleic acid sequences encoding them. Their use in vaccines and in screening methods is also described.
|
|
|
US20080069833 |
YEAST-BASED VACCINES AS IMMUNOTHERAPY
Compositions and methods for treating and/or preventing a variety of diseases and conditions that are amenable to immunotherapy and, in one particular embodiment, compositions and methods for...
|
|
|
US20080063655 |
Brachyspira hyodysenteriae vaccine
The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of...
|
|
|
US20080050398 |
Composition Comprising Beta-Defensin 2
The invention relates to compositions comprising at least one peptide with a structure or structural pattern of β-defensin 2 and/or its derivatives, especially human β-defensin 2. The...
|
|
|
US20080038319 |
Transformed Bacteria Producing CS6 Antigens as Vaccines
Disclosed herein are antigens that stimulate protective antibodies against enterotoxigenic Escherichia coli . Also disclosed herein are proteins encoded by cssA and cssB genes as well as...
|
|
|
US20080038287 |
Method For Identification, Isolation and Production of Antigens to a Specific Pathogen
Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to autoimmunity,...
|
|
|
US20080038268 |
Streptococcus Pyogenes Antigens
The present invention relates to antigens, more particularly an antigen of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which is useful as vaccine...
|
|
|
US20080031889 |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
|
|
|
US20080025999 |
YERSINIA SPECIES COMPOSITIONS
A method of protecting an animal from infections with pathogens originating from Yersinia comprising administering an isolated or recombinant YscF protein to the animal is disclosed. The isolated...
|
|
|
US20080025998 |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chilamydia
The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of...
|
|
|
US20080003234 |
Secreted campylobacter flagella coregulated proteins as immunogens
The invention relates to an immunogenic composition composed of secreted polypeptides derived from Campylobacter jejuni non-flagellar proteins that are coordinately expressed with the flagellar...
|